Hyde-Smith Votes to Stop Dems' Abortion on Demand "til Birth Bill

Press Release

U.S. Senator Cindy Hyde-Smith (R-Miss.) today voted to stop Senate Democrats from advancing a House-passed abortion bill that would have effectively codified Roe v. Wade and struck down pro-life laws across the nation.

Prior to voting, Hyde-Smith participated in a news conference to blast the legislation and the Senate Democrats' focus on promoting abortions on demand as the nation deals with a struggling economy and international strife. The Senate voted 46-48 on HR.3755, short of the 60 votes required to proceed.

"If the Democrats were being honest, the bill would be titled, "The Abortion On Demand Until Birth Act,' because that's what it is. The "Women's Health Protection Act.' Are you kidding me? This is not protecting women's health. It has nothing to do with protecting women's health and everything to do with making abortion on demand just the law of the land," Hyde-Smith said.

"There's no need for this bill or today's vote, especially when Americans know there are many more critical needs right now going on in this country and around the globe. It is simply out of touch with the views of the American people," she said.

While the U.S. Supreme Court nears a ruling on a Mississippi law in a case that could effectively overturn Roe, HR.3755 would instead codify Roe and nullify every state law regulating abortion. This would include laws restricting late-term abortions and laws prohibiting abortions performed because of the race, sex, or condition of the child. It would also terminate informed-consent laws.

Hyde-Smith noted that the scope of the bill indicates how out of touch the Democrats are with Americans, 65 percent of whom believe states should oversee abortion laws, 65 percent of whom oppose abortion in the second trimester, and 80 percent of whom oppose abortion in the third trimester.

Last week, Hyde-Smith and U.S. Congressman Bob Latta (R-Ohio) led a letter signed by 126 Senators and Representatives demanding the U.S. Food and Drug Administration (FDA) immediately restore more stringent oversight of chemical abortion pills, including the in-person dispensing requirement the FDA suspended in December. Their letter arrived the same week as a report that showed more than half of U.S. abortions are now carried out with abortion-inducing pills.

Source